These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2435738)

  • 21. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J; Guidicelli H; Glanddier G; Mosnier M
    Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL; Zelenock GB; Whitehouse WM; Lindenauer SM; Graham LM; Stanley JC
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment by transcutaneous PO2 measurement of the treatment of venous ulcers with naftidrofuryl].
    Kalis B
    J Mal Vasc; 1984; 9(2):133-6. PubMed ID: 6747475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of naftidrofuryl on the ischemia model in healthy probands].
    Rudofsky G
    Vasa; 1988; 17(3):199-207. PubMed ID: 3051762
    [No Abstract]   [Full Text] [Related]  

  • 26. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 27. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of intravenous naftidrofuryl on transcutaneous oxygen pressure in severe peripheral vascular disease.
    Taggart I; Wishart GC; Cuschieri RJ; MacBain GC
    Angiology; 1989 Oct; 40(10):895-8. PubMed ID: 2802260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
    Abendroth D; Sunder-Plassmann L
    Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
    [No Abstract]   [Full Text] [Related]  

  • 31. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
    Fiessinger JN; Schäfer M
    Lancet; 1990 Mar; 335(8689):555-7. PubMed ID: 1689791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound].
    Weidinger P
    Med Welt; 1983 Apr; 34(17):531-4. PubMed ID: 6865725
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of naftidrofuryl ('Praxilene') on hepatic microsomal enzymes.
    Majumdar SK; Shaw GK; Thomson AD
    Pharmatherapeutica; 1980; 2(5):305-8. PubMed ID: 6107932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calf sweat lactate in peripheral arterial occlusive disease.
    Fellmann N; Fabry R; Coudert J
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H395-8. PubMed ID: 2764127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of naftidrofuryl oxalate (Praxilene) on blood flow in the experimental saphenous flap model.
    Awwad AM; White RJ; Webster MH; Vance JP
    Br J Plast Surg; 1983 Oct; 36(4):460-2. PubMed ID: 6626826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S
    Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
    [No Abstract]   [Full Text] [Related]  

  • 39. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
    Rey JL; Quiret JC; Gamain J; Errasti M
    Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
    Bianchi G
    Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.